Pdx1 and other factors that regulate pancreatic β-cell survival

Diabetes, Obesity and Metabolism

Volumn 11, Issue SUPPL. 4, 2009, Pages 30-37

  Fujimoto, K ^a   Polonsky, K S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Autophagy; Necrosis; Pdx1; cell mass

Indexed keywords

FATTY ACID; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; SOMATOMEDIN; TRANSCRIPTION FACTOR PDX 1;

APOPTOSIS; ARTICLE; AUTOPHAGY; CELL DEATH; CELL SURVIVAL; DIABETES MELLITUS; DIABETOGENESIS; DYSLIPIDEMIA; HUMAN; HYPERGLYCEMIA; INSULIN RELEASE; INTRAUTERINE GROWTH RETARDATION; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PANCREAS ISLET DISEASE; PREGNANCY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CELL COUNT; CELL SURVIVAL; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; INSULIN-SECRETING CELLS; MICE; TRANS-ACTIVATORS;

EID: 70350291205     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2009.01121.x     Document Type: Article

References (71)

1. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev 2001, 15:111-127.
2. Butler PC, Meier JJ, Butler AE, Bhushan A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab 2007, 3:758-768.
3. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371:606-609.
4. Brooke NM, Garcia-Fern àndez J, Holland PW. The ParaHox gene cluster is an evolutionary sister of the Hox gene cluster. Nature 1998, 392:920-922.
5. Rosanas-Urgell A, Marfany G, Garcia-Fern àndez J. Pdx1-related homeodomain transcription factors are distinctly expressed in mouse adult pancreatic islets. Mol Cell Endocrinol 2005, 237:59-66.
6. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997, 15:106-110.
7. Stoffers DA, Stanojevic V, Habener JF. Insulin promoter factor-1 gene mutation linked to early-onset type 2 diabetes mellitus directs expression of a dominant negative isoprotein. J Clin Invest 1998, 102:232-241.
8. Hani EH, Stoffers DA, Chevre JC. Defective mutations in the insulin promoter factor-1 (ipf-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 1999, 104:41-48.
9. Clocquet AR, Egan JM, Stoffers D. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (insulin promoter factor 1 gene). Diabetes 2000, 49:1856-1864.
10. Macfarlane WM, Frayling TM, Ellard S. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999, 104:33-39.
11. Weir GC, Sharma A, Zangen DH, Bonner-Weir S. Transcription factor abnormalities as a cause of beta cell dysfunction in diabetes: a hypothesis. Acta Diabetol 1997, 34:177-184.
12. Bernardo AS, Hay CW, Docherty K. Pancreatic transcription factors and their role in the birth, life and survival of the pancreatic beta cell. Mol Cell Endocrinol 2008, 294:1-9.
13. Wilson ME, Scheel D, German MS. Gene expression cascades in pancreatic development. Mech Dev 2003, 120:65-80.
14. Servitja JM, Ferrer J. Transcriptional networks controlling pancreatic development and beta cell function. Diabetologia 2004, 47:597-613.
15. Guz Y, Montminy MR, Stein R. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 1995, 121:11-18.
16. Bonner-Weir S. Life and death of the pancreatic beta cells. Trends Endocrinol Metab 2000, 11:375-378.
17. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 1995, 44:249-256.
18. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004, 429:41-46.
19. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 2007, 12:817-826.
20. Scarlatti F, Granata R, Meijer AJ, Codogno P. Does autophagy have a license to kill mammalian cells?. Cell Death Differ 2008, 16:12-20.
21. Chang-Chen KJ, Mullur R, Bernal-Mizrachi E. Beta-cell failure as a complication of diabetes. Rev Endocr Metab Disord 2008, 9:329-343.
22. Kulkarni RN, Br üning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999, 96:329-339.
23. Otani K, Kulkarni RN, Baldwin AC. Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in betaIRKO mice. Am J Physiol Endocrinol Metab 2004, 286:E41-E49.
24. Withers DJ, Gutierrez JS, Towery H. Disruption of IRS-2 causes type 2 diabetes in mice. Nature 1998, 391:900-904.
25. Kubota N, Tobe K, Terauchi Y. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 2000, 49:1880-1889.
26. Lu Y, Herrera PL, Guo Y. Pancreatic-specific inactivation of IGF-I gene causes enlarged pancreatic islets and significant resistance to diabetes. Diabetes 2004, 53:3131-3141.
27. Kitamura T, Nakae J, Kitamura Y. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 2002, 110:1839-1847.
28. Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, Kahn CR. PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 2004, 114:828-836.
29. Okamoto H, Hribal ML, Lin HV, Bennett WR, Ward A, Accili D. Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. J Clin Invest 2006, 116:775-782.
30. Tanabe K, Liu Z, Patel S. Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance. PLoS Biol 2008, 6:307-318.
31. Boucher MJ, Selander L, Carlsson L, Edlund H. Phosphorylation marks ipf1/pdx1 protein for degradation by glycogen synthase kinase 3-dependent mechanisms. J Biol Chem 2006, 281:6395-6403.
32. Robertson LA, Kim AJ, Werstuck GH. Mechanisms linking diabetes mellitus to the development of atherosclerosis: A role for endoplasmic reticulum stress and glycogen synthase kinase-3. Can J Physiol Pharmacol 2006, 84:39-48.
33. Kahn SE, Carr DB, Faulenbach MV, Utzschneider KM. An examination of beta-cell function measures and their potential use for estimating beta-cell mass. Diabetes Obes Metab 2008, 4:63-76.
34. Hagman DK, Latour MG, Chakrabarti SK. Cyclical and alternating infusions of glucose and intralipid in rats inhibit insulin gene expression and Pdx-1 binding in islets. Diabetes 2008, 57:424-431.
35. Fornoni A, Pileggi A, Molano RD. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 2008, 51:298-308.
36. Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and beta-cell dysfunction. Endocr Rev 2008, 29:351-366.
37. Khaldi MZ, Guiot Y, Gilon P, Henquin JC, Jonas JC. Increased glucose sensitivity of both triggering and amplifying pathways of insulin secretion in rat islets cultured for 1 wk in high glucose. Am J Physiol Endocrinol Metab 2004, 287:E207-E217.
38. Wajchenberg BL. Beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 2007, 28:187-218.
39. Finegood DT, McArthur MD, Kojwang D. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001, 50:1021-1029.
40. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 2003, 52:102-110.
41. Harmon JS, Gleason CE, Tanaka Y, Poitout V, Robertson RP. Antecedent hyperglycemia, not hyperlipidemia, is associated with increased islet triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats. Diabetes 2001, 50:2481-2486.
42. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004, 279:42351-42354.
43. Tanaka Y, Gleason CE, Tran PO, Harmon JS, Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci U S A 1999, 96:10857-10862.
44. Tanaka Y, Tran PO, Harmon J, Robertson RP. A role for glutathione peroxidase in protecting pancreatic beta cells against oxidative stress in a model of glucose toxicity. Proc Natl Acad Sci U S A 2002, 99:12363-12368.
45. Kaneto H, Kajimoto Y, Miyagawa J. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 1999, 48:2398-2406.
46. Shimano H. SREBPs: physiology and pathophysiology of the SREBP family. FEBS J 2009, 276:616-621.
47. Ishikawa M, Iwasaki Y, Yatoh S. Cholesterol accumulation and diabetes in pancreatic beta-cell-specific SREBP-2 transgenic mice: a new model for lipotoxicity. J Lipid Res 2008, 49:2524-2534.
48. Wang H, Kouri G, Wollheim CB. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity. J Cell Sci 2005, 118:3905-3915.
49. Johnson JD, Bernal-Mizrachi E, Alejandro EU. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci U S A 2006, 103:19575-19580.
50. Johnson JD, Ahmed NT, Luciani DS. Increased islet apoptosis in Pdx1+/- mice. J Clin Invest 2003, 111:1147-1160.
51. Brissova M, Shiota M, Nicholson WE. Reduction in pancreatic transcription factor PDX-1 impairs glucose-stimulated insulin secretion. J Biol Chem 2002, 277:11225-11232.
52. Li Y, Cao X, Li LX, Brubaker PL, Edlund H, Drucker DJ. beta-cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes 2005, 54:482-491.
53. Karnik SK, Chen H, McLean GW. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 2007, 318:806-809.
54. Park JH, Stoffers DA, Nicholls RD, Simmons RA. Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J Clin Invest 2008, 118:2316-2324.
55. Klonsky DJ. Autophagy: from phenomenology to molecular understanding in less than a decade. Nat Rev Mol Cell Biol 2007, 8:931-937.
56. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008, 132:27-42.
57. Mortimore GE, Pösö AR. Intracellular protein catabolism and its control during nutrient deprivation and supply. Annu Rev Nutr 1987, 7:539-564.
58. Shimizu S, Kanaseki T, Mizushima N. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol 2004, 6:1221-1228.
59. Yu L, Alva A, Su H. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.
60. Marsh BJ, Soden C, Alarcón C. Regulated autophagy controls hormone content in secretory-deficient pancreatic endocrine beta-cells. Mol Endocrinol 2007, 21:2255-2269.
61. Ebato C, Uchida T, Arakawa M. Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. Cell Metab 2008, 8:325-332.
62. Jung HS, Chung KW, Won Kim J. Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. Cell Metab 2008, 8:318-324.
63. Kaniuk NA, Kiraly M, Bates H, Vranic M, Volchuk A, Brumell JH. Ubiquitinated-protein aggregates form in pancreatic beta-cells during diabetes-induced oxidative stress and are regulated by autophagy. Diabetes 2007, 56:930-939.
64. Shvets E, Elazar Z. Autophagy-independent incorporation of GFP-LC3 into protein aggregates is dependent on its interaction with p62/SQSTM1. Autophagy 2008, 4:1054-1056.
65. Fujimoto K, Hanson PT, Tran H. Autophagy regulates pancreatic beta cell death in response to Pdx1 deficiency and nutrient deprivation. J Biol Chem 2009, doi: 10.1074/jbc.M109
66. Steer SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1 stimulates beta-cell necrosis and release of the immunological adjuvant HMGB1. PLoS Med 2006, 3:253-266.
67. Han J, Zhong J, Wei W. Extracellular high-mobility group box 1 acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice. Diabetes 2008, 57:2118-2127.
68. Hagman DK, Hays LB, Parazzoli SD, Poitout V. Palmitate inhibits insulin gene expression by altering pdx-1 nuclear localization and reducing mafa expression in isolated rat islets of langerhans. J Biol Chem 2005, 280:32413-32418.
69. Macfarlane WM, McKinnon CM, Felton-Edkins ZA, Cragg H, James RF, Docherty K. Glucose stimulates translocation of the homeodomain transcription factor pdx1 from the cytoplasm to the nucleus in pancreatic beta-cells. J Biol Chem 1999, 274:1011-1016.
70. Kitamura YI, Kitamura T, Kruse JP. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metab 2005, 2:153-163.
71. Moede T, Leibiger B, Pour HG, Berggren P, Leibiger IB. Identification of a nuclear localization signal, rrmkwkk, in the homeodomain transcription factor pdx-1. FEBS Lett 1999, 461:229-234.